openpr
Organoids Market to Eyewitness Massive Growth by 2029: Merck, Prellis Biologics, amsbio
March 06, 2023.
With our unique core technology in advanced bioprinting & tissue engineering, Prellis 3D printed lymph nodes replicate the immune system as an accessible, scalable platform to discover novel targets & therapeutic antibodies with the power to predict, test & select the best candidates at an unprecedented speed, accelerating therapeutics into clinical trials.
openpr
March 06, 2023.
owensoutlook
February 28, 2023.
The Brown Daily Herald
October 19, 2022.